钼靶联合超声诊断乳腺良恶性病变的应用有效性探讨
原桂梅 庞永亮【摘要】目的:探讨钼靶联合超声诊断乳腺良恶性病变的应用有效性。方法:抽选本院于2020年1月—2022年12月间收治的106例行手术治疗的乳腺肿块患者,給予钼靶诊断、超声诊断以及两种方式的联合诊断,对比单独诊断和联用诊断方式的准确率。结果:在106例患者中,经病理诊断后,恶性病变患者74例(69.81%),良性病变32例(30.18%)。经诊断,联合诊断的准确率明显高于钼靶诊断、超声诊断的准确率,统计学有意义(P<0.05)。联合诊断的特异度90.62%和敏感度98.64%明显高于超声诊断、钼靶诊断;联合诊断的误诊率0.94%、漏诊率2.83%明显低于超声诊断、钼靶诊断(P<0.05)。结论:在乳腺良恶性病变的临床诊断中,采用钼靶联合超声诊断,其诊断准确率高,值得临床推广和使用。
【关键词】钼靶;超声诊断;乳腺良恶性病变;有效性
The application of molybdenum target combined with ultrasound in the diagnosis of benign and malignant breast lesions
YUAN Guimei1, PANG Yongliang2
1.The 943rd Hospital of the Joint Service Support Force of the Chinese People’s Liberation Army, Wuwei, Gansu 733000, China 2.Liangzhou Hospital, Wuwei, Gansu 733000, China
【Abstract】Objective: To explore the effectiveness of molybdenum target combined with ultrasound in the diagnosis of benign and malignant breast lesions. Methods: 106 patients with breast masses who received surgical treatment in our hospital from January 2020 to December 2022 were selected and given molybdenum target diagnosis ......
您现在查看是摘要页,全文长 9286 字符。